Outcome
    Moderate Evidence

    Bacopa Monnieri for Neuroprotection

    Bacopa shows neuroprotective activity in animal models, but no human trial has tested protection against neurodegeneration.

    Overview

    Bacopa shows neuroprotective activity in animal models, but no human trial has tested protection against neurodegeneration.

    Verdict

    Insufficient evidence

    How It Works

    Bacosides reduce beta-amyloid aggregation and neuronal oxidative stress and upregulate antioxidant enzymes in rodent models of neurotoxicity.

    Dosing & Protocol

    Typical dose

    Recommended dose
    No established dose for neuroprotection; cognition trials used 300-450 mg/day
    Expected timeframe
    Not established

    Protocol

    studied dose
    300-450 mg/day of extract standardised to 50% bacosides in the human trials, which measured short-term cognitive performance only
    evidence note
    Verdict is insufficient - the neuroprotection case is preclinical
    what happened
    Preclinical evidence for antioxidant, anti-amyloid and neuronal protective effects is broad and reasonably consistent, but human data cover only short-term cognitive performance in healthy adults - no trial has measured dementia incidence, brain imaging or disease progression
    better evidenced
    Blood pressure control, exercise, hearing correction and sleep have far stronger neuroprotection evidence
    if you still trial it
    300 mg/day with a fat-containing meal for 12 weeks, judged on a delayed recall test rather than on animal mechanism

    Evidence

    What the studies say

    Preclinical evidence is broad and reasonably consistent; human data cover only short-term cognitive performance in healthy adults. Extrapolating from rodent neuroprotection to human disease prevention is unwarranted.

    No studies are yet linked to both Bacopa Monnieri and Neuroprotection.

    Safety

    Caveats

    Extrapolating rodent neuroprotection to human disease prevention has repeatedly failed - treat this as unproven. Gastrointestinal upset is common; take with food. Cholinergic activity means caution with anticholinergics, cholinesterase inhibitors, and in bradycardia, asthma and peptic ulcer disease. May raise thyroid hormones. Long-term safety beyond 12 months is not established. Not established as safe in pregnancy or breastfeeding - avoid.

    Less likely to help if

    People with established dementia or neurodegenerative disease, where no benefit has been shown.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.